Cloning Resources
  Recent News |  Tags |  Organ & Tissue Cloning |  Animal Cloning |  Definitions |  Archives |  About |  Newsletter |  Subscribe to CloningResources.com RSS Fee Subscribe

Researchers Identify Antioxidant Mechanisms Involved in Protection Against Cardiovascular Disease (5/4/2007)

Tags:
progenitor cells, heart

Zvonimir Katusic, M.D., Ph.D., and Mayo colleagues have identified antioxidant mechanisms essential for regenerative function of endothelial progenitor cells (EPCs). "This work paves the way for successful harnessing of the therapeutic effect of EPCs in the prevention and treatment of cardiovascular diseases," Dr. Katusic says. The study will be presented during the 2007 Experimental Biology meeting in Washington, D.C., on April 29.

EPCs move from the bone marrow into the bloodstream to repair the endothelium during a heart attack or stroke. The endothelium is a single layer of cells that line the inner surface of blood vessels. It protects tissues against the formation of blood clots in arteries and veins. If the endothelium is not working properly, patients are at risk for developing heart disease, stroke, peripheral vascular disease and venous thrombosis.

Normally, when EPCs move into the bloodstream, the body can restore cardiovascular functions that may have gone awry. EPCs are resistant to stress and are capable of repairing the endothelium even under conditions of extreme ischemia (inadequate supply of oxygen to an organ). But when EPCs are in insufficient supply, they are unable to protect the body from heart disease or stroke.

The antioxidant mechanism Dr. Katusic and colleagues identified includes enzymes that protect EPCs from oxidative stress in diseased arteries and veins. Oxidative stress is a consequence of the elevated production of free radicals that are associated with the inability of the antioxidant system to prevent free radicals from imposing tissue damage.

These research findings will lead to improved understanding of the molecular design of EPCs, says Dr. Katusic, a specialist in cardiovascular pharmacology at Mayo Clinic's campus in Rochester, Minn.

The study was funded by the National Heart Lung and Blood Institute.

Note: This story has been adapted from a news release issued by the Mayo Clinic

Homeowner Loan - New York Hotel - Savings Accounts - Secured Loans

Post Comments:

Search

Recent Articles
Immune response to human embryonic stem cells in mice suggests human therapy may face challenge 8/20/2008

Hydrogels provide scaffolding for growth of bone cells 8/19/2008

Neuroscientist awarded $3 million state stem cell grant 8/18/2008

Fifth young Stanford scientist gets stem cell funding from state institute 8/17/2008

Researchers Discover Tiny Cellular Antennae Trigger Neural Stem Cells 8/16/2008

Newly discovered molecular switch helps decide cell type in early embryo development 8/13/2008

Scientists identify single microRNA that controls blood vessel development 8/12/2008

Daley and colleagues create 20 disease-specific stem cell lines 8/9/2008

Putting microRNAs on the stem cell map 8/8/2008

Protein Key to Control Growth of Blood Cells 8/7/2008

Study finds molecule triggers hair growth in mouse embryos 8/6/2008

New $8.9 million project aims to unlock stem cell secrets 8/5/2008

Stanford fruit-fly study adds weight to theories about another type of adult stem cell 8/3/2008

First disease-specific stem cells from human skin cells 8/2/2008

Stem Cell Foundation plays critical funding role in major new ALS research announced today 8/1/2008

  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
All contents © 2000 - 2009 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer